Zongru Jiang

473 total citations
19 papers, 270 citations indexed

About

Zongru Jiang is a scholar working on Molecular Biology, Hematology and Genetics. According to data from OpenAlex, Zongru Jiang has authored 19 papers receiving a total of 270 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 6 papers in Hematology and 4 papers in Genetics. Recurrent topics in Zongru Jiang's work include Acute Myeloid Leukemia Research (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Quinazolinone synthesis and applications (3 papers). Zongru Jiang is often cited by papers focused on Acute Myeloid Leukemia Research (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Quinazolinone synthesis and applications (3 papers). Zongru Jiang collaborates with scholars based in China and United States. Zongru Jiang's co-authors include Jing Liu, Aoli Wang, Qingsong Liu, Chen Hu, Li Wang, Wenliang Wang, Ziping Qi, Zhenquan Hu, Cheng Chen and Fengming Zou and has published in prestigious journals such as SHILAP Revista de lepidopterología, Journal of Medicinal Chemistry and European Journal of Pharmacology.

In The Last Decade

Zongru Jiang

19 papers receiving 267 citations

Peers

Zongru Jiang

ONCOL

PRM

Elisabetta Di Bello Italy

Jae Hoo Park South Korea

Anatoly Prokvolit United States

Marlena Walls United States

Corinne Rossi United States

Patrizia Maddalena Italy

Hiromi Kazuno Japan

Abdellatif Amri Canada

Bret Bannerman United States

Elisabetta Di Bello Italy

Zongru Jiang

232 ×1.4

74 ×1.5

ONCOL

66 ×1.6

46 ×1.2

33 ×0.9

PRM

Citations per year, relative to Zongru Jiang Zongru Jiang (= 1×) peers Elisabetta Di Bello

Countries citing papers authored by Zongru Jiang

Since Specialization

Citations

This map shows the geographic impact of Zongru Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zongru Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zongru Jiang more than expected).

Fields of papers citing papers by Zongru Jiang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zongru Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zongru Jiang. The network helps show where Zongru Jiang may publish in the future.

Co-authorship network of co-authors of Zongru Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Zongru Jiang. A scholar is included among the top collaborators of Zongru Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zongru Jiang. Zongru Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

Mei, Husheng, Jing Yang, Bin Zhou, et al.. (2023). Discovery of IHMT-337 as a potent irreversible EZH2 inhibitor targeting CDK4 transcription for malignancies. Signal Transduction and Targeted Therapy. 8(1). 18–18. 19 indexed citations

Wang, Aoli, Juan Liu, Xixiang Li, et al.. (2023). Discovery of a highly potent pan-RAF inhibitor IHMT-RAF-128 for cancer treatment. European Journal of Pharmacology. 952. 175752–175752. 2 indexed citations

Hong, Wu, Juan Ge, Fengming Zou, et al.. (2023). Pharmacological inhibiting STAT5 for the treatment of FLT3‐ITD‐positive acute myeloid leukemia with triciribine phosphate monohydrate. SHILAP Revista de lepidopterología. 4(4). e294–e294. 2 indexed citations

Liu, Juan, Jingjing Gao, Aoli Wang, et al.. (2022). Nintedanib overcomes drug resistance from upregulation of FGFR signalling and imatinib‐induced KIT mutations in gastrointestinal stromal tumours. Molecular Oncology. 16(8). 1761–1774. 7 indexed citations

Zhou, Bin, Xiaofei Liang, Husheng Mei, et al.. (2021). Discovery of IHMT-EZH2-115 as a Potent and Selective Enhancer of Zeste Homolog 2 (EZH2) Inhibitor for the Treatment of B-Cell Lymphomas. Journal of Medicinal Chemistry. 64(20). 15170–15188. 18 indexed citations

Li, Feng, Xiaofei Liang, Zongru Jiang, et al.. (2020). Discovery of (S)-2-(1-(4-Amino-3-(3-fluoro-4-methoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)propyl)-3-cyclopropyl-5-fluoroquinazolin-4(3H)-one (IHMT-PI3Kδ-372) as a Potent and Selective PI3Kδ Inhibitor for the Treatment of Chronic Obstructive Pulmonary Disease. Journal of Medicinal Chemistry. 63(22). 13973–13993. 12 indexed citations

Wang, Wenliang, Zongru Jiang, Li Wang, et al.. (2020). All-trans retinoic acid exerts selective anti-FLT3-ITD acute myeloid leukemia efficacy through downregulating Chk1 kinase. Cancer Letters. 473. 130–138. 7 indexed citations

Wang, Wenliang, Zongru Jiang, Chen Hu, et al.. (2020). Pharmacologically inhibiting phosphoglycerate kinase 1 for glioma with NG52. Acta Pharmacologica Sinica. 42(4). 633–640. 30 indexed citations

Chen, Cheng, Hong Wu, Zuowei Wang, et al.. (2020). Osimertinib successfully combats EGFR-negative glioblastoma cells by inhibiting the MAPK pathway. Acta Pharmacologica Sinica. 42(1). 108–114. 25 indexed citations

10.

Wang, Beilei, Xuesong Liu, Fengming Zou, et al.. (2020). Discovery of (E)-N-(4-methyl-5-(3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)thiazol-2-yl)-2-(4-methylpiperazin-1-yl)acetamide (IHMT-TRK-284) as a novel orally available type II TRK kinase inhibitor capable of overcoming multiple resistant mutants. European Journal of Medicinal Chemistry. 207. 112744–112744. 15 indexed citations

11.

Liang, Xiaofei, Zongru Jiang, Zhenghui Huang, et al.. (2019). Discovery of 6′-chloro-N-methyl-5’-(phenylsulfonamido)-[3,3′-bipyridine]-5-carboxamide (CHMFL-PI4K-127) as a novel Plasmodium falciparum PI(4)K inhibitor with potent antimalarial activity against both blood and liver stages of Plasmodium. European Journal of Medicinal Chemistry. 188. 112012–112012. 16 indexed citations

12.

Lu, Tingting, Cheng Chen, Aoli Wang, et al.. (2019). Repurposing cabozantinib to GISTs: Overcoming multiple imatinib-resistant cKIT mutations including gatekeeper and activation loop mutants in GISTs preclinical models. Cancer Letters. 447. 105–114. 12 indexed citations

13.

Jiang, Zongru, Li Wang, Xuesong Liu, et al.. (2019). Discovery of a highly selective VEGFR2 kinase inhibitor CHMFL-VEGFR2-002 as a novel anti-angiogenesis agent. Acta Pharmaceutica Sinica B. 10(3). 488–497. 29 indexed citations

14.

Liu, Xuesong, Beilei Wang, Cheng Chen, et al.. (2019). Discovery of (E)-N¹-(3-Fluorophenyl)-N³-(3-(2-(pyridin-2-yl)vinyl)-1H-indazol-6-yl)malonamide (CHMFL-KIT-033) as a Novel c-KIT T670I Mutant Selective Kinase Inhibitor for Gastrointestinal Stromal Tumors (GISTs). Journal of Medicinal Chemistry. 62(10). 5006–5024. 16 indexed citations

15.

Wang, Li, Chen Hu, Aoli Wang, et al.. (2019). Discovery of a novel and highly selective CDK9 kinase inhibitor (JSH-009) with potent antitumor efficacy in preclinical acute myeloid leukemia models. Investigational New Drugs. 38(5). 1272–1281. 10 indexed citations

16.

Liang, Xiaofei, Cheng Chen, Zongru Jiang, et al.. (2018). Discovery of (S)-2-amino-N-(5-(6-chloro-5-(3-methylphenylsulfonamido)pyridin-3-yl)-4-methylthiazol-2-yl)-3-methylbutanamide (CHMFL-PI3KD-317) as a potent and selective phosphoinositide 3-kinase delta (PI3Kδ) inhibitor. European Journal of Medicinal Chemistry. 156. 831–846. 12 indexed citations

17.

Wang, Qiang, Feiyang Liu, Shuang Qi, et al.. (2018). Discovery of 4-((N-(2-(dimethylamino)ethyl)acrylamido)methyl)-N-(4-methyl-3-((4-(pyridin-3-yl)pyrimidin-2-yl)amino)phenyl)benzamide (CHMFL-PDGFR-159) as a highly selective type II PDGFRα kinase inhibitor for PDGFRα driving chronic eosinophilic leukemia. European Journal of Medicinal Chemistry. 150. 366–384. 15 indexed citations

18.

Wan, Lijuan, Lingli Gong, Ran An, et al.. (2015). T. gondii rhoptry protein ROP18 induces apoptosis of neural cells via endoplasmic reticulum stress pathway. Parasites & Vectors. 8(1). 554–554. 22 indexed citations

19.

Jiang, Zongru, et al.. (2015). [Construction and Identification of Transgenic Strain of Toxoplasma gondii High-expressing Virulence Factor ROP18].. PubMed. 33(1). 14–8. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact